Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: Experience from a single center

Journal of Invasive Cardiology

Volumn 23, Issue 3, 2011, Pages 101-104

  Singh, Avneet ^a   Edasery, David ^b   Noor, Amir ^c   Bhasin, Nalina ^a   Kaplan, Barry ^a   Jauhar, Rajiv ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; AGED; ANGIOPLASTY; ARTERY GRAFT; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG INFUSION; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; FEMORAL ARTERY; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RADIAL ARTERY; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; TRANSFEMORAL PERCUTANEOUS CORONARY INTERVENTION; TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION; TREATMENT DURATION; TREATMENT OUTCOME; CORONARY ARTERY DISEASE; DOSE RESPONSE; FEASIBILITY STUDY; HEART INFARCTION; INCIDENCE; METHODOLOGY; MIDDLE AGED; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; ANTITHROMBINS; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; FEMALE; FEMORAL ARTERY; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; RADIAL ARTERY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960053995     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Singh M, Rihal CS, Gersh BJ, et al. Twenty-five-year trends in in-hospital and longterm outcome after percutaneous coronary intervention: A single-institution experience. Circulation 2007;115:2835-2841. Epub 2007 May 28. (Pubitemid 46869670)
2. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The ACCESS study. J Am Coll Cardiol 1997;29:1269-1275. (Pubitemid 27201945)
3. Louvard Y, Lefevre T, Allain A, et al. Coronary angiography through the radial or femoral approach: The CARAFE study. Catheter Cardiovasc Interv 2001;52:181-187. (Pubitemid 32115130)
4. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140. Epub 2008 Nov 1.
5. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989;16:3-7. (Pubitemid 19033502)
6. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn 1993;30:173-178. (Pubitemid 23292091)
7. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv 2008;1:379-386.
8. Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. J Am Coll Cardiol Intv 2008;1:202-209. (Pubitemid 351506552)
9. Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009;10:88-93.
10. Lincoff AM, Bittl JA, Harrington RA, Feit F, et al; REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863. (Pubitemid 37430344)
11. Jabara R, Gadesam R, Pendyala L, et al. Ambulatory discharge after transradial coronary intervention: Preliminary U.S. single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study). Am Heart J 2008;156:1141-1146. Epub 2008 Oct 9.
12. Bertrand OF, Larose E, Rodés-Cabau J, et al. Incidence, predictors and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. Am Heart J 2009;157:164-169.
13. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-356. (Pubitemid 38950594)